Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders

 
 

ALLOS THERAPEUTICS INC (ALTH) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $1.87 Metrics
OS: 107.0 M -46 % ROE
Market cap: $200 M
Net cash: $87.6 M $0.82 per share
EV: $112 M

 
TTM Valuation
EBITDA ($36.0) M
EBIT ($36.9) M
EPS ($0.35)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Sep-01-07Dec-31-06Sep-01-06
Revenues76.035.23.630.623.0125.314.3107.9
            Revenue growth115.9%882.6%-88.3%33.1%60.5%16.2%27.7%15.3%
Cost of goods sold0.50.50.130.623.0104.515.584.8
Gross profit75.634.83.50.00.020.8-1.223.0
            Gross margin99.4%98.7%96.6%0.0%0.0%16.6%-8.4%21.4%
Selling, general and administrative67.878.844.423.019.7102.814.983.2
Research and development22.231.432.6     
EBIT-30.5-77.5-73.6-53.6-42.7-262.7-31.5-220.1
            EBIT margin-40.2%-220.0%-2053.8%-175.3%-185.6%-209.7%-219.8%-204.0%
Pre-tax income-30.5-77.5-73.6-51.7-39.4-237.7-30.2-198.3
Income taxes0.0-0.1-0.10.00.00.00.00.0
            Tax rate0.0%0.1%0.1%0.0%0.0%0.0%0.0%0.0%
Net income-30.5-77.4-73.6-51.7-39.4-237.7-30.2-198.3
            Net margin-40.1%-219.8%-2051.7%-169.1%-171.2%-189.7%-210.9%-183.9%
 
Diluted EPS($0.29)($0.74)($0.81)($0.69)($0.60) ($0.55) 
Shares outstanding (diluted)105.7105.190.575.465.2 55.3 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy